Gottlieb A B
Clinical Research Center, UMDNJ-Robert Wood Johnson Medical School, 51 French St., New Brunswick, NJ 08901-0019, USA.
Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv58-60. doi: 10.1136/ard.2005.042655.
Alefacept is a bioengineered fusion protein of soluble lymphocyte function antigen (LFA-3) with Fc fragments of IgG1. It is marketed in many countries for the treatment of moderate to severe psoriasis. This paper reviews the data supporting the use of alefacept in psoriasis and psoriatic arthritis.
阿法赛特是一种生物工程融合蛋白,由可溶性淋巴细胞功能抗原(LFA-3)与IgG1的Fc片段组成。它在许多国家上市用于治疗中度至重度银屑病。本文综述了支持阿法赛特用于银屑病和银屑病关节炎的数据。